<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31856677</PMID><DateCompleted><Year>2021</Year><Month>01</Month><Day>29</Day></DateCompleted><DateRevised><Year>2021</Year><Month>04</Month><Day>22</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1551-4005</ISSN><JournalIssue CitedMedium="Internet"><Volume>19</Volume><Issue>2</Issue><PubDate><Year>2020</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Cell cycle (Georgetown, Tex.)</Title><ISOAbbreviation>Cell Cycle</ISOAbbreviation></Journal><ArticleTitle>Downregulation of miR-155-5p facilitates enterovirus 71 replication through suppression of type I IFN response by targeting FOXO3/IRF7 pathway.</ArticleTitle><Pagination><StartPage>179</StartPage><EndPage>192</EndPage><MedlinePgn>179-192</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1080/15384101.2019.1704512</ELocationID><Abstract><AbstractText>Enterovirus 71 (EV71), the major cause of hand-foot-and-mouth disease (HFMD), has evolved diverse strategies to counter the type I interferon (IFN-I) response during infection. Recently, microRNAs have regulatory roles in host innate immune responses to viral infections; however, whether EV71 escapes the IFN-I antiviral response through regulation of miRNAs remains unclear. Using a microarray assay, microRNA-155-5p (miR-155-5p) was found to be significantly up-regulated in serum from patients with EV71 infection and the increased expression of miR-155-5p was further confirmed <i>in vivo</i> and <i>in vitro</i> in response to EV71 infection. miR-155-5p overexpression suppressed EV71 titers and VP1 protein level, while miR-155-5p inhibition had an opposite result. Moreover, we found that miR-155-5p overexpression enhanced EV71 triggered IFN I production and the expressions of IFN-stimulated genes (ISGs), while inhibition of miR-155-5p suppressed these processes. Furthermore, bioinformatics analysis and luciferase reporter assay demonstrated that miR-155-5p directly targeted forkhead box protein O3 (FOXO3) and negatively regulated FOXO3/IRF7 axis, an important regulatory pathway for type I IFN production during EV71 infection. Inhibition of FOXO3 reversed the effects of miR-155-5p inhibitor on EV71 replication and the type I IFN production. Importantly, in EV71 infection mice, agomir-155-5p injection resulted in a significant reduction of viral VP1 protein expressions in brain and lung tissues, increased IFN-&#x3b1;/&#x3b2; production and increased mice survival rate. In contrast, antagomir-155-5p enhanced EV71 induced these effects. Collectively, our study indicates that weaken miR-155-5p facilitates EV71 replication through suppression of type I IFN response by FOXO3/IRF7 pathway, thereby suggesting a novel strategy for developing effective antiviral therapy.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Daokun</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Infectious Disease III, The First Affiliated Hospital of Xinxiang Medical University, Weihui, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Xinwei</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Infectious Disease III, The First Affiliated Hospital of Xinxiang Medical University, Weihui, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gao</LastName><ForeName>Haili</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Infectious Disease III, The First Affiliated Hospital of Xinxiang Medical University, Weihui, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Baoxin</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Infectious Disease III, The First Affiliated Hospital of Xinxiang Medical University, Weihui, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Si</LastName><ForeName>Changyun</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Infectious Disease III, The First Affiliated Hospital of Xinxiang Medical University, Weihui, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Shasha</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Infectious Disease III, The First Affiliated Hospital of Xinxiang Medical University, Weihui, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>12</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cell Cycle</MedlineTA><NlmUniqueID>101137841</NlmUniqueID><ISSNLinking>1551-4005</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C499517">FOXO3 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000071316">Forkhead Box Protein O3</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C494234">IRF7 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D050839">Interferon Regulatory Factor-7</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007370">Interferon Type I</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C524942">MIRN155 microRNA, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D035683">MicroRNAs</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001483" MajorTopicYN="N">Base Sequence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015536" MajorTopicYN="N">Down-Regulation</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004770" MajorTopicYN="N">Enterovirus</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="N">Enterovirus Infections</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000071316" MajorTopicYN="N">Forkhead Box Protein O3</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D050839" MajorTopicYN="N">Interferon Regulatory Factor-7</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007370" MajorTopicYN="N">Interferon Type I</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008810" MajorTopicYN="N">Mice, Inbred C57BL</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D035683" MajorTopicYN="N">MicroRNAs</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015398" MajorTopicYN="Y">Signal Transduction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014779" MajorTopicYN="Y">Virus Replication</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Enterovirus 71</Keyword><Keyword MajorTopicYN="N">FOXO3/IRF7 pathway</Keyword><Keyword MajorTopicYN="N">miR-155-5p</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>12</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>1</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>12</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>12</Month><Day>19</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31856677</ArticleId><ArticleId IdType="pmc">PMC6961679</ArticleId><ArticleId IdType="doi">10.1080/15384101.2019.1704512</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Yip CC, Lau SK, Woo PC, et al. Human enterovirus 71 epidemics: what&#x2019;s next? Emerg Health Threats J. 2013;6:19780.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3772321</ArticleId><ArticleId IdType="pubmed">24119538</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Q, Xiong Y, Xu J, et al. Host microRNA hsa-miR-494-3p promotes EV71 replication by directly targeting PTEN. Front Cell Infect Microbiol. 2018;8:278.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6130220</ArticleId><ArticleId IdType="pubmed">30234021</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan LG, Parashar UD, Lye MS, et al. Deaths of children during an outbreak of hand, foot, and mouth disease in sarawak, malaysia: clinical and pathological characteristics of the disease. For the Outbreak Study Group. Clinl Infect Dis. 2000;31:678&#x2013;683.</Citation><ArticleIdList><ArticleId IdType="pubmed">11017815</ArticleId></ArticleIdList></Reference><Reference><Citation>Stifter SA, Feng CG.. Interfering with immunity: detrimental role of type I IFNs during infection. J Iimmunol. 2015;194:2455&#x2013;2465.</Citation><ArticleIdList><ArticleId IdType="pubmed">25747907</ArticleId></ArticleIdList></Reference><Reference><Citation>Killip MJ, Fodor E, Randall RE.. Influenza virus activation of the interferon system. Virus Res. 2015;209:11&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4638190</ArticleId><ArticleId IdType="pubmed">25678267</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmann HH, Schneider WM, Rice CM. Interferons and viruses: an evolutionary arms race of molecular interactions. Trends Immunol. 2015;36:124&#x2013;138.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4384471</ArticleId><ArticleId IdType="pubmed">25704559</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen W, Han C, Xie B, et al. Induction of siglec-G by RNA viruses inhibits the innate immune response by promoting RIG-I degradation. Cell. 2013;152:467&#x2013;478.</Citation><ArticleIdList><ArticleId IdType="pubmed">23374343</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu Y, Zhang L, Zhang F, et al. Exosome-mediated miR-146a transfer suppresses type I interferon response and facilitates EV71 infection. PLoS Pathog. 2017;13:e1006611.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5614653</ArticleId><ArticleId IdType="pubmed">28910400</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng C, Zheng Z, Sun J, et al. MiR-16-5p mediates a positive feedback loop in EV71-induced apoptosis and suppresses virus replication. Sci Rep. 2017;7:16422.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5703983</ArticleId><ArticleId IdType="pubmed">29180670</ArticleId></ArticleIdList></Reference><Reference><Citation>Honda K, Yanai H, Negishi H, et al. IRF-7 is the master regulator of type-I interferon-dependent immune responses. Nature. 2005;434:772&#x2013;777.</Citation><ArticleIdList><ArticleId IdType="pubmed">15800576</ArticleId></ArticleIdList></Reference><Reference><Citation>Sato M, Suemori H, Hata N, et al. Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-alpha/beta gene induction. Immunity. 2000;13:539&#x2013;548.</Citation><ArticleIdList><ArticleId IdType="pubmed">11070172</ArticleId></ArticleIdList></Reference><Reference><Citation>He L, Hannon GJ. MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet. 2004;5:522&#x2013;531.</Citation><ArticleIdList><ArticleId IdType="pubmed">15211354</ArticleId></ArticleIdList></Reference><Reference><Citation>Yao L, Wu CX, Zheng K, et al. Immunogenic response to a recombinant pseudorabies virus carrying bp26 gene of Brucella melitensis in mice. Res Vet Sci. 2015;100:61&#x2013;67.</Citation><ArticleIdList><ArticleId IdType="pubmed">25890577</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen L, Song Y, He L, et al. MicroRNA-223 promotes type I interferon production in antiviral innate immunity by Targeting forkhead box protein O3 (FOXO3). J Biol Chem. 2016;291:14706&#x2013;14716.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4938189</ArticleId><ArticleId IdType="pubmed">27226534</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma Y, Wang C, Xue M, et al. The coronavirus transmissible gastroenteritis virus evades the type I interferon response through IRE1alpha-mediated manipulation of the microRNA miR-30a-5p/SOCS1/3 axis. J Virol. 2018;92:e00728-18.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6206482</ArticleId><ArticleId IdType="pubmed">30185587</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y, He S, Wang J. MicroRNA-373 facilitates HSV-1 replication through suppression of type I IFN response by targeting IRF1. Biomed Pharmacothe. 2018;97:1409&#x2013;1416.</Citation><ArticleIdList><ArticleId IdType="pubmed">29156530</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng N, Zhou Z, Li Y, et al. Enterovirus 71-induced has-miR-21 contributes to evasion of host immune system by targeting MyD88 and IRAK1. Virus Res. 2017;237:27&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pubmed">28506791</ArticleId></ArticleIdList></Reference><Reference><Citation>Stanic M. A simplification of the estimation of the 50 percent endpoints according to the Reed and Muench method. Pathologia et microbiologia. 1963;26:298&#x2013;302.</Citation><ArticleIdList><ArticleId IdType="pubmed">13983379</ArticleId></ArticleIdList></Reference><Reference><Citation>Mei LL, Wang WJ, Qiu YT, et al. miR-125b-5p functions as a tumor suppressor gene partially by regulating HMGA2 in esophageal squamous cell carcinoma. PloS One. 2017;12:e0185636.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5624607</ArticleId><ArticleId IdType="pubmed">28968424</ArticleId></ArticleIdList></Reference><Reference><Citation>Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001;25:402&#x2013;408.</Citation><ArticleIdList><ArticleId IdType="pubmed">11846609</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren L, Zhao Y, Huo X, et al. MiR-155-5p promotes fibroblast cell proliferation and inhibits FOXO signaling pathway in vulvar lichen sclerosis by targeting FOXO3 and CDKN1B. Gene. 2018;653:43&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pubmed">29339071</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu H, Huang T, Ying L, et al. MiR-155 is involved in renal ischemia-reperfusion injury via direct targeting of FoxO3a and regulating renal tubular cell pyroptosis. Cell Physiol Biochem. 2016;40:1692&#x2013;1705.</Citation><ArticleIdList><ArticleId IdType="pubmed">28006785</ArticleId></ArticleIdList></Reference><Reference><Citation>Li B, Zheng J. MicroR-9-5p suppresses EV71 replication through targeting NFkappaB of the RIG-I-mediated innate immune response. FEBS Open Bio. 2018;8:1457&#x2013;1470.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6120239</ArticleId><ArticleId IdType="pubmed">30186747</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang YF, Chou CT, Lei HY, et al. A mouse-adapted enterovirus 71 strain causes neurological disease in mice after oral infection. J Virol. 2004;78:7916&#x2013;7924.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC446098</ArticleId><ArticleId IdType="pubmed">15254164</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho BC, Yu IS, Lu LF, et al. Inhibition of miR-146a prevents enterovirus-induced death by restoring the production of type I interferon. Nat Commun. 2014;5:3344.</Citation><ArticleIdList><ArticleId IdType="pubmed">24561744</ArticleId></ArticleIdList></Reference><Reference><Citation>Bao JL, Lin L. MiR-155 and miR-148a reduce cardiac injury by inhibiting NF-kappaB pathway during acute viral myocarditis. Eur Rev Med Pharmacol Sci. 2014;18:2349&#x2013;2356.</Citation><ArticleIdList><ArticleId IdType="pubmed">25219837</ArticleId></ArticleIdList></Reference><Reference><Citation>Pareek S, Roy S, Kumari B, et al. MiR-155 induction in microglial cells suppresses Japanese encephalitis virus replication and negatively modulates innate immune responses. J Neuroinflammation. 2014;11:97.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4050406</ArticleId><ArticleId IdType="pubmed">24885259</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie C, Ren GL, Xu MC, et al. The effect of miR-155 on HBV replication and PTEN expression in vivo. Zhonghua Gan Zang Bing Za Zhi. 2018;26:489&#x2013;494.</Citation><ArticleIdList><ArticleId IdType="pubmed">30317769</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang B, Fu M, Liu Y, et al. gga-miR-155 enhances type I interferon expression and suppresses infectious burse disease virus replication via targeting SOCS1 and TANK. Front Cell Infect Microbiol. 2018;8:55.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5845882</ArticleId><ArticleId IdType="pubmed">29564226</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta R, Arkatkar T, Keck J, et al. Antigen specific immune response in Chlamydia muridarum genital infection is dependent on murine microRNAs-155 and &#x2212;182. Oncotarget. 2016;7:64726&#x2013;64742.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5323111</ArticleId><ArticleId IdType="pubmed">27556515</ArticleId></ArticleIdList></Reference><Reference><Citation>Cordey S, Petty TJ, Schibler M, et al. Identification of site-specific adaptations conferring increased neural cell tropism during human enterovirus 71 infection. PLoS Pathog. 2012;8:e1002826.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3406088</ArticleId><ArticleId IdType="pubmed">22910880</ArticleId></ArticleIdList></Reference><Reference><Citation>Strauss M, Filman DJ, Belnap DM, et al. Nectin-like interactions between poliovirus and its receptor trigger conformational changes associated with cell entry. J Virol. 2015;89:4143&#x2013;4157.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4442392</ArticleId><ArticleId IdType="pubmed">25631086</ArticleId></ArticleIdList></Reference><Reference><Citation>Rasti M, Khanbabaei H, Teimoori A. An update on enterovirus 71 infection and interferon type I response. Rev Med Virol. 2019;29:e2016.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7169063</ArticleId><ArticleId IdType="pubmed">30378208</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang J, Jiao J, Xu W, et al. MiR-155 is upregulated in patients with active tuberculosis and inhibits apoptosis of monocytes by targeting FOXO3. Mol Med Rep. 2015;12:7102&#x2013;7108.</Citation><ArticleIdList><ArticleId IdType="pubmed">26324048</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao Y, Liu Z, Ding Z, et al. MicroRNA-155 increases colon cancer chemoresistance to cisplatin by targeting forkhead box O3. Oncol Lett. 2018;15:4781&#x2013;4788.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5840649</ArticleId><ArticleId IdType="pubmed">29552117</ArticleId></ArticleIdList></Reference><Reference><Citation>Litvak V, Ratushny AV, Lampano AE, et al. A FOXO3-IRF7 gene regulatory circuit limits inflammatory sequelae of antiviral responses. Nature. 2012;490:421&#x2013;425.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3556990</ArticleId><ArticleId IdType="pubmed">22982991</ArticleId></ArticleIdList></Reference><Reference><Citation>He X, Teng J, Cui C, et al. MicroRNA-182 inhibits HCMV replication through activation of type I IFN response by targeting FOXO3 in neural cells. Exp Cell Res. 2018;369:197&#x2013;207.</Citation><ArticleIdList><ArticleId IdType="pubmed">29792850</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang LY, Huang LM, Gau SS, et al. Neurodevelopment and cognition in children after enterovirus 71 infection. N Engl J Med. 2007;356:1226&#x2013;1234.</Citation><ArticleIdList><ArticleId IdType="pubmed">17377160</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang CC, Liu CC, Chang YC, et al. Neurologic complications in children with enterovirus 71 infection. N Engl J Med. 1999;341:936&#x2013;942.</Citation><ArticleIdList><ArticleId IdType="pubmed">10498488</ArticleId></ArticleIdList></Reference><Reference><Citation>Bochnakian A, Zhen A, Zisoulis DG, et al. Interferon-inducible miR-128 modulates HIV-1 replication by targeting TNPO3 mRNA. J Virol. 2019;93:e00364-19.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6798100</ArticleId><ArticleId IdType="pubmed">31341054</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X, Guo Y, Xu X, et al. miR-146a promotes Borna disease virus 1 replication through IRAK1/TRAF6/NF-kappaB signaling pathway. Virus Res. 2019;271:197671.</Citation><ArticleIdList><ArticleId IdType="pubmed">31330207</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang K, Lai C, Gu H, et al. miR-194 inhibits innate antiviral immunity by targeting FGF2 in influenza H1N1 virus infection. Front Microbiol. 2017;8:2187.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5674008</ArticleId><ArticleId IdType="pubmed">29163456</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun Y, Feng L, Li J, et al. miR-545 promoted enterovirus 71 replication via directly targeting phosphatase and tensin homolog and tumor necrosis factor receptor-associated factor 6. J Cell Physiol. 2019;234:15686&#x2013;15697.</Citation><ArticleIdList><ArticleId IdType="pubmed">30697739</ArticleId></ArticleIdList></Reference><Reference><Citation>Wen BP, Dai HJ, Yang YH, et al. MicroRNA-23b inhibits enterovirus 71 replication through downregulation of EV71 VPl protein. Intervirology. 2013;56:195&#x2013;200.</Citation><ArticleIdList><ArticleId IdType="pubmed">23594713</ArticleId></ArticleIdList></Reference><Reference><Citation>Sadler AJ, Williams BR. Interferon-inducible antiviral effectors. Nat Rev Immunol. 2008;8:559&#x2013;568.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2522268</ArticleId><ArticleId IdType="pubmed">18575461</ArticleId></ArticleIdList></Reference><Reference><Citation>Schoggins JW, Rice CM. Interferon-stimulated genes and their antiviral effector functions. Curr Opin Virol. 2011;1:519&#x2013;525.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3274382</ArticleId><ArticleId IdType="pubmed">22328912</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhai T, Wu C, Wang N, et al. Development of a monoclonal antibody against swine leukocyte antigen (SLA)-DR alpha chain and evaluation of SLA-DR expression in bone marrow-derived dendritic cells after PRRSV infection. Vet Immunol Immunopathol. 2019;211:19&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pubmed">31084889</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang P, Hou J, Lin L, et al. Inducible microRNA-155 feedback promotes type I IFN signaling in antiviral innate immunity by targeting suppressor of cytokine signaling 1. J Iimmunol. 2010;185:6226&#x2013;6233.</Citation><ArticleIdList><ArticleId IdType="pubmed">20937844</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu X, Cai X, Zhang D, et al. Zebrafish foxo3b negatively regulates antiviral response through suppressing the transactivity of irf3 and irf7. J Iimmunol. 2016;197:4736&#x2013;4749.</Citation><ArticleIdList><ArticleId IdType="pubmed">27815423</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>